Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Long COVID
Long COVID
Genetic breakthroughs could point pharma to a long COVID drug
Pharma Voice
Tue, 04/22/25 - 11:02 am
Long COVID
genetics
drug discovery
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Reuters
Sun, 06/9/24 - 11:29 pm
Pfizer
Paxlovid
Long COVID
COVID-19
Researchers link immune dysfunction to long COVID, opening door to new treatments
Fierce Biotech
Fri, 01/19/24 - 09:46 am
immune system
COVID-19
Long COVID
Axcella granted patent for long COVID fatigue treatment
Medical Marketing and Media
Wed, 08/30/23 - 11:21 pm
Axcella Therapeutics
COVID-19
Long COVID
AXA1125
patents
Study mapping how SARS-CoV-2 disrupts mitochondria suggests a cause for long Covid
Stat
Thu, 08/10/23 - 09:56 am
COVID-19
Long COVID
mitochondria
US to test Paxlovid as long COVID-19 therapy
Beckers Hospital Review
Wed, 08/2/23 - 10:22 am
clinical trials
Long COVID
Pfizer
Paxlovid
NIH
NIH begins long-delayed clinical trials for long Covid, announces new research office
Stat
Tue, 08/1/23 - 11:52 am
NIH
COVID-19
Long COVID
clinical trials
New Yale study evaluates PAXLOVID's use in Long COVID recovery
Drugs.com
Tue, 03/21/23 - 09:49 pm
Pfizer
Paxlovid
COVI-19
Long COVID
clinical trials
'We beg you': Biotechs plead for help and funds to find long COVID treatments
Fierce Biotech
Wed, 02/22/23 - 06:59 pm
COVID-19
Long COVID
funding
biotech
Axcella Health
Flagship Pioneering
Axcella Clears Regulatory Path for Long COVID Therapeutic
BioSpace
Tue, 01/24/23 - 06:16 pm
Axcella Therapeutics
Long COVID
COVID-19
AXA1125
UK
Axcella axes NASH program, 85% of staff in last-ditch focus on long COVID
Fierce Biotech
Thu, 12/15/22 - 11:18 am
Axcella Therapeutics
NASH
layoffs
COVID-19
Long COVID
Researchers Are Studying Whether Paxlovid Can Treat Long COVID
Time
Thu, 12/1/22 - 10:49 am
Pfizer
Paxlovid
COVID-19
Long COVID
Vaccinated people up to 80% less likely to have long COVID-19: study
Beckers Hospital Review
Wed, 09/14/22 - 08:17 pm
Long COVID
vaccines
COVID-19
A long Covid collaborative kicks off with $15M to study causes of lingering disease, conduct clinical trials
Endpoints
Thu, 09/8/22 - 11:41 am
Dr. Patrick Soon-Shiong
R&D
Long COVID
COVID-19
Axcella previews long Covid registrational trial plans in UK and US
Clinical Trials Arena
Wed, 08/3/22 - 10:45 am
Axcella Health
Long COVID
COVID-19
clinical trials
Long COVID Evidence Begins to Mount, Suggesting Biomarkers and a "Triangle" Effect
BioSpace
Mon, 07/11/22 - 10:40 am
biomarkers
COVID-19
Long COVID
Axcella's CEO knows people are tired of the pandemic. But long COVID patients need help, too
Fierce Biotech
Tue, 06/21/22 - 11:04 am
Axcella Health
COVID-19
Long COVID
Large UK study suggests vaccination helps treat long COVID
Pharmaforum
Thu, 05/19/22 - 10:41 am
COVID-19
vaccines
Long COVID
Could Pfizer's Paxlovid or other antivirals help cure long COVID?
Fierce Pharma
Mon, 04/18/22 - 10:46 am
Pfizer
Paxlovid
Long COVID
COVID-19
antivirals
Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms
Endpoints
Sun, 03/27/22 - 03:58 pm
COVID-19
Long COVID
GSK
Vir Biotechnology
Humanigen
Pfizer
Roche
Atea Pharmaceuticals
Pages
1
2
next ›
last »